TY  - JOUR

T1  - Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation

JO  - Health Technology Assessment

UR  - https://eprints.whiterose.ac.uk/id/eprint/162546

PY  - 2020/06/01

AU  - Davis S

AU  - Simpson E

AU  - Hamilton J

AU  - James MM-S

AU  - Rawdin A

AU  - Wong R

AU  - Goka E

AU  - Gittoes N

AU  - Selby P

ED  - 

DO  - DOI: 10.3310/hta24290

PB  - National Institute for Health Research

VL  - 24

IS  - 29

Y2  - 2024/12/22

ER  -